NCT00967889

Brief Summary

RATIONALE: Studying samples of tissue, blood, and urine from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat the cancer. PURPOSE: This research study is looking at tissue, blood, and urine samples from patients with advanced prostate cancer.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2002

Completed
7.7 years until next milestone

First Submitted

Initial submission to the registry

August 27, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 28, 2009

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Last Updated

August 12, 2013

Status Verified

August 1, 2009

Enrollment Period

9.4 years

First QC Date

August 27, 2009

Last Update Submit

August 9, 2013

Conditions

Prostate Cancer

Keywords

stage III prostate cancerstage IV prostate cancerrecurrent prostate cancer

Outcome Measures

Primary Outcomes (3)

  • Molecular pathology and mechanisms of disease progression

  • Development of novel treatment strategies for patients with advanced prostate cancer

  • Evaluation of novel markers and treatment and epidemiological approaches

Interventions

gene expression analysisGENETIC
protein analysisGENETIC
biologic sample preservation procedureOTHER
laboratory biomarker analysisOTHER

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
DISEASE CHARACTERISTICS: * Diagnosis of advanced prostate cancer PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Cancer Research UK at Cambridge Research Institute

Cambridge, England, CB2 0RE, United Kingdom

RECRUITING

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Gene Expression Profiling

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Genetic TechniquesInvestigative Techniques

Study Officials

  • David Neil, MD

    Cancer Research UK

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 27, 2009

First Posted

August 28, 2009

Study Start

January 1, 2002

Primary Completion

June 1, 2011

Last Updated

August 12, 2013

Record last verified: 2009-08

Locations

GB(1)